Bin Liang

15PUBLICATIONS
40CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Systems physiologyHaematological tumoursMedical virologyEpidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jul 15, 2026
FOLFOX-HAIC plus regorafenib for the treatment of unresectable colorectal liver metastases refractory to first and second-line systemic chemotherapy.

|Jan 21, 2026
Clinical outcomes after TIPS: comparison of patients with a history of partial splenic embolization vs splenectomy in cirrhosis.

Dan Zhao, Jiacheng Liu, Jiayu Wan

|Jan 16, 2025
Age and clinical spectrum of COVID-19 are associated with safety of transarterial chemoembolization in hepatocellular carcinoma: a retrospective cohort study.

Zizhuo Wang, Tingting Yang, Lijie Zhang

|Jan 15, 2025
Transarterial Chemoembolization Plus Radiofrequency Ablation and Iodine-125 Seed Implantation for Hepatocellular Carcinoma in High-Risk Locations: A Propensity Score-Matched Analysis.

Guilin Zhang, Yanqiao Ren, Jiayun Liu

|Oct 01, 2024
Detecting Cellular Microstructural Changes of Liver Fibrosis with Time-Dependent Diffusion MRI.

Lijie Zhang, Xi Long, Leqing Chen

|Jun 17, 2024
Efficacy and Safety of Transarterial Chemoembolization and Repeated Partial Splenic Embolization for Hepatocellular Carcinoma with Hypersplenism and Thrombocytopenia.

Wei Hong, Zizhuo Wang, Wei Yao

Pageof 3

Frequent Collaborators

4 joint publications

Lijie Zhang

3 joint publications

Chuansheng Zheng

2 joint publications

Fu Xiong

2 joint publications

Lei Chen